10x Genomics Inc (NASDAQ:TXG) currently has a daily average trading volume of 3.60M but it saw 2617830 shares traded in last market. With a market cap of 1.07B USD, the company’s current market price of $8.54 came rising about 2.64 while comparing to the previous closing price of $8.32. In past 52 weeks, the stock remained buoying in the range of price level as high as $24.76 and as low as $6.78.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Leerink Partners which downgraded the stock as “Market Perform” in its note to investors issued on February 13, 2025, recommending a price target of between $25 and $12 for it. Jefferies issued its recommendations for the stock as it upgraded the price target for the stock is $24.
Over the week, TXG’s stock price is moving -7.17% down while it is 6.55% when we observe its performance for the past one month. Year-to-date it is -40.53% down and over the past year, the stock is showing a downside performance of -65.61%.
Currently, 10x Genomics Inc’s total number of outstanding shares is 109.08M with 1.87% of that held by the insiders while 103.86% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -20.20% and return on equity (ROE) at -22.03%. Stock’s beta reads 1.95. Stock has a price to book (P/B) ratio of 1.49 while price to sale or P/S ratio amounts to 1.71. Its return on asset (ROA) is -17.20% on average.
